Topical questions of beta-blockers application in clinical practice
The present review shows the modern view on the possibilities of beta-blockers application in different clinical situations. The class of beta-blockers is a heterogeneous group in terms of clinical usage. The recent critical comments by some researchers on beta-blocker therapy should not misguide th...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2014-12-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/viewFile/29066/pdf |
id |
doaj-aeb7465af8d14d75badc490d134a5229 |
---|---|
record_format |
Article |
spelling |
doaj-aeb7465af8d14d75badc490d134a52292020-11-25T03:22:54ZrusIP Morozov P.V.Системные гипертензии2075-082X2542-21892014-12-01114717426167Topical questions of beta-blockers application in clinical practiceD V NebieridzeThe present review shows the modern view on the possibilities of beta-blockers application in different clinical situations. The class of beta-blockers is a heterogeneous group in terms of clinical usage. The recent critical comments by some researchers on beta-blocker therapy should not misguide the practitioners, who always need to ask themselves the question: what kind of clinical situations and specific beta-blockers are discussed. Some beta-blockers, especially non-selective ones, could demonstrate negative effects and are contraindicated in specific clinical situations (metabolic disorders, COPD, peripheral arterial disease). Modern super-selective beta-blockers such as Betaloc ZOK did not have these negative effect sand could be widely used in clinical practice, even in patients with metabolic syndrome, DM-2 and COPD.Another problem associated with the application of beta-blockers is not frequent prescription or usage of beta-blockers in subthreshold dose.https://syst-hypertension.ru/2075-082X/article/viewFile/29066/pdfbeta-blockersmetabolic effectsheart ratebetaloc zok |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
D V Nebieridze |
spellingShingle |
D V Nebieridze Topical questions of beta-blockers application in clinical practice Системные гипертензии beta-blockers metabolic effects heart rate betaloc zok |
author_facet |
D V Nebieridze |
author_sort |
D V Nebieridze |
title |
Topical questions of beta-blockers application in clinical practice |
title_short |
Topical questions of beta-blockers application in clinical practice |
title_full |
Topical questions of beta-blockers application in clinical practice |
title_fullStr |
Topical questions of beta-blockers application in clinical practice |
title_full_unstemmed |
Topical questions of beta-blockers application in clinical practice |
title_sort |
topical questions of beta-blockers application in clinical practice |
publisher |
IP Morozov P.V. |
series |
Системные гипертензии |
issn |
2075-082X 2542-2189 |
publishDate |
2014-12-01 |
description |
The present review shows the modern view on the possibilities of beta-blockers application in different clinical situations. The class of beta-blockers is a heterogeneous group in terms of clinical usage. The recent critical comments by some researchers on beta-blocker therapy should not misguide the practitioners, who always need to ask themselves the question: what kind of clinical situations and specific beta-blockers are discussed. Some beta-blockers, especially non-selective ones, could demonstrate negative effects and are contraindicated in specific clinical situations (metabolic disorders, COPD, peripheral arterial disease). Modern super-selective beta-blockers such as Betaloc ZOK did not have these negative effect sand could be widely used in clinical practice, even in patients with metabolic syndrome, DM-2 and COPD.Another problem associated with the application of beta-blockers is not frequent prescription or usage of beta-blockers in subthreshold dose. |
topic |
beta-blockers metabolic effects heart rate betaloc zok |
url |
https://syst-hypertension.ru/2075-082X/article/viewFile/29066/pdf |
work_keys_str_mv |
AT dvnebieridze topicalquestionsofbetablockersapplicationinclinicalpractice |
_version_ |
1724608822722428928 |